×
About 658 results

ALLMedicine™ Adult-onset Still's Disease Center

Research & Reviews  252 results

Latent class analysis of 216 patients with adult-onset Still's disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722082
Arthritis Research & Therapy; Sugiyama T, Furuta S et. al.

Jan 5th, 2022 - Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disease which encompasses patients with heterogenous presentation and a wide range of clinical courses. In this study, we aimed to identify potential subgroups of AOSD and reve...

Clinical phenotypes and prognostic factors of adult-onset Still's disease: data from a ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653615
Arthritis Research & Therapy; Li R, Liu X et. al.

Dec 10th, 2021 - To define different clinical phenotypes and assess prognostic factors of adult-onset Still's disease (AOSD). Overall, 492 patients with AOSD seen between 2004 and 2018 at a single centre were retrospectively studied. Of these patients, 78% were fe...

Adult-onset Still's disease after environmental exposure while working in Africa.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557289
BMJ Case Reports; Gilbert EL, Wang B

Oct 30th, 2021 - Adult-onset Still's disease (AOSD) is characterised by a constellation of systemic inflammatory symptoms and typical laboratory findings like hyperferritinaemia. A high index of suspicion is needed to identify patients as diagnosis is primarily cl...

Adult-onset Still's disease with multiple lymphadenopathy: a case report and literature...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549178
Diagnostic Pathology; Huang Z, Xu H et. al.

Oct 29th, 2021 - Adult-onset Still's disease (AOSD) often presents with systemic multiple lymphadenopathy. In addition to the common paracortical and mixed patterns in AOSD lymph node histopathological features, other morphological patterns include diffuse, necrot...

see more →

Clinicaltrials.gov  2 results

Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and Adults
https://clinicaltrials.gov/ct2/show/NCT05055882

Sep 24th, 2021 - Adult-Onset Still's disease is a polygenic autoinflammatory disease of unknown etiology. The autoinflammatory character individualizes it from autoimmune autoantibody diseases. Clinically, it results in the classic triad associating hectic fever, ...

Multi-center Registration Study of Adult Onset Still's Disease in Chinese Population
https://clinicaltrials.gov/ct2/show/NCT03651193

Feb 2nd, 2021 - Backgrounds: Adult-onset Still's disease (AOSD) is a rare systemic clinical syndrome of unknown etiology. Its pathogenesis is complex, often thought to be affected by infection, genetic and immune factors. Due to the low incidence of adult Still's...

see more →

News  9 results

NICE Recommends Anakinra for Paediatric and Adult-onset Still’s Disease
https://www.medscape.com/viewarticle/948506

Apr 1st, 2021 - The National Institute for Health and Care Excellence (NICE) has recommended anakinra (Kineret, Swedish Orphan Biovitrum) as a treatment option for Still’s disease in adults and systemic juvenile idiopathic arthritis in children. Anakinra is an in...

FDA Approves Canakinumab (Ilaris), First Drug for Adult-Onset Still's Disease
https://www.medscape.com/viewarticle/932625

Jun 19th, 2020 - The Food and Drug Administration has expanded the indications for canakinumab (Ilaris) to include all patients with active Still's disease older than 2 years, adding adult-onset Still's disease (AOSD) to a previous approval for juvenile-onset Stil...

Rheumatologists: On the COVID-19 Front Line
https://www.medpagetoday.com/infectiousdisease/covid19/85545

Mar 22nd, 2020 - Rheumatologists may be in a unique position to consult and help in the management of patients with severe disease caused by COVID-19, said experts. "Some of the drugs that appear promising for patients who are severely ill with COVID-19 are those ...

Lethal Lung Disease and Biologics: Is There a Link?
https://www.medpagetoday.com/rheumatology/arthritis/84098

Dec 24th, 2019 - This story was originally published Sept. 4, 2019. As part of MedPage Today's year-end review of 2019's top stories, we are republishing it along with an update on what has happened since. A new, potentially life-threatening parenchymal lung disea...

Lethal Lung Disease and Biologics: Is There a Link?
https://www.medpagetoday.com/rheumatology/arthritis/81966

Sep 4th, 2019 - A new, potentially life-threatening parenchymal lung disease is increasingly being detected in patients with systemic juvenile idiopathic arthritis (sJIA), according to recent reports. Systemic JIA is distinct from other forms of JIA in that the a...

see more →